WANT MORE TOP STOCK PICKS?

We just dropped a new batch of winners inside Crown Elite — and you’re invited.

Our Latest pick ONDS is up over 80% since SEP 12.

3 STOCK PICKS THIS WEEK

1 year performance

  1. ILMN - 20%

  2. LYFT - 55%

  3. NBIS - 498%

This Week (Here’s our top 3 stock picks)

  1. Illumina, Inc. (ILMN)

1 Year Chart:

Buy Level: Available in Crown Elite

Stop Loss: Available in Crown Elite

Price Target: Available in Crown Elite

Market Cap: $18.52B

Company Info:

Illumina Inc. (NASDAQ: ILMN) is a global leader in genomics and DNA sequencing technologies, providing advanced tools that power genetic research, diagnostics, and precision medicine. The company’s innovative sequencing platforms and bioinformatics solutions enable scientists, healthcare providers, and biotech companies to decode the human genome with unprecedented accuracy and efficiency. Illumina’s mission is to improve human health by unlocking the power of the genome, driving breakthroughs in cancer detection, rare disease research, reproductive health, and personalized medicine—positioning it at the forefront of the genomic revolution shaping the future of healthcare.

Why it’s a buy:

The stock is a buy in 2025 because Illumina Inc. (ILMN) remains a global leader in genomics and DNA sequencing, positioned at the heart of the rapidly expanding precision medicine and biotechnology industries. The company’s sequencing platforms and bioinformatics tools are foundational to breakthroughs in cancer detection, genetic testing, and drug discovery, giving it a dominant position in a market projected to grow exponentially as healthcare becomes more personalized and data-driven.

Following years of restructuring and renewed focus on core innovation, Illumina is entering a phase of margin recovery and pipeline expansion, supported by demand from pharma, diagnostics, and research institutionsworldwide. As governments, hospitals, and biotech firms continue investing in genomic medicine, ILMN stands out as a long-term growth play on the global adoption of DNA sequencing and the next generation of healthcare innovation.

  1. Lyft, Inc. (LYFT)

1 Year Chart:

Buy Level: Available in Crown Elite

Stop Loss: Available in Crown Elite

Price Target: Available in Crown Elite

Market Cap: $8B

Company Info:

Lyft Inc. (NASDAQ: LYFT) is a leading ride-sharing and transportation technology company focused on transforming the way people move through cities. Its platform connects millions of riders and drivers across North America, offering on-demand transportation, shared rides, and micromobility solutions such as bikes and scooters. Lyft’s mission is to improve people’s lives with the world’s best transportation, creating safer, more sustainable, and more accessible mobility ecosystems while driving innovation in electric and autonomous vehicle integration to shape the future of urban transportation.

Why it’s a buy:

The stock is a buy in 2025 because Lyft Inc. (LYFT) is strengthening its position as a leading ride-sharing and urban mobility platform, benefiting from the ongoing recovery in travel, commuting, and live events. With a renewed focus on profitability, operational efficiency, and driver retention, Lyft has streamlined costs while expanding margins—transforming from a growth-at-all-costs startup into a sustainable, cash-generating transportation business.

The company is also investing in AI-driven pricing, routing, and safety systems, improving rider experience and driver earnings while expanding into electric vehicles, bikes, and autonomous mobility partnerships. As cities continue to embrace shared and eco-friendly transportation models, LYFT stands out as a leveraged play on the mobility rebound, offering investors exposure to the future of on-demand, connected, and sustainable urban transportation.

Revenue:

  1. Nebius Group N.V. (NBIS)

1 Year Chart:

Buy Level: Available in Crown Elite

Stop Loss: Available in Crown Elite

Price Target: Available in Crown Elite

Market Cap: $30.25B

Company Info:

Nebius Group N.V. (NASDAQ: NBIS) is a leading AI and cloud computing infrastructure company that provides high-performance, scalable, and energy-efficient platforms for artificial intelligence, machine learning, and data-intensive applications. The company designs and operates advanced data centers and cloud environments optimized for next-generation workloads, enabling enterprises, research institutions, and developers to accelerate innovation across industries. Nebius’s mission is to power the global AI economythrough sustainable, high-performance cloud solutions, positioning itself as a key enabler of the digital transformation and intelligent computing revolution.

Why it’s a buy:

The stock is a buy in 2025 because Nebius Group N.V. (NBIS) is emerging as a key player in the rapidly expanding AI infrastructure and cloud computing sector, providing the high-performance backbone needed to power the next wave of artificial intelligence and machine learning applications. The company operates advanced, energy-efficient data centers that deliver scalable compute capacity for enterprises, startups, and research institutions across the globe.

With the global surge in demand for AI training, large-scale data processing, and cloud-based workloads, Nebius is positioned to capture strong growth momentum as organizations shift toward specialized, high-performance computing environments. Its focus on sustainability, efficiency, and technological innovationprovides a competitive edge against legacy cloud providers. As AI adoption accelerates across every industry, NBIS stands out as a pure-play opportunity in the AI infrastructure boom, offering investors long-term exposure to one of the fastest-growing segments in global technology.

Revenue:

WANT MORE TOP STOCK PICKS?

We just dropped a new batch of winners inside Crown Elite — and you’re invited.

Premium stock picks all week (Mon, Wed, Fri)

Exclusive Discord access to my private trade chat

Weekly elite watchlists every Sunday

Buy Levels, Price Targets and Stop Losses to keep you ahead

Full access to the stock pick archives + download vault

If you’ve found value in these emails… this is the next step.

👇 Tap below to get full access:

SOME OF OUR RECENT ELITE ALERTS:

DAVE +211%

PLTR +92.3%

HOOD +95.9%

Our Partners:

The #1 Trading Software in the world: Tradingview

Thank you for your time!

Stay tuned for our next free release every Monday!

Disclaimer: The stocks mentioned in this email do not represent the exact positions of Crown Trading, but rather ideas and opportunities we are currently monitoring. Just because a stock is featured here does not mean we own or are actively trading it. The buy levels are not recommendations. This is not financial advice, and neither myself nor Crown Trading is recommending that you buy or sell any securities. All information is for educational purposes only and should not be relied upon for investment decisions. Please do your own research before making any trades.

Keep Reading

No posts found